glp 1 rhabdomyolysis GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome glp 1 rhabdomyolysis GLP-1R signalling

Study: The effectiveness of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on binge eating in patients with obesity: a systematic review and meta-analysis

This program includes: Compounded Semaglutide Medication

Although this new agent (cagrilintide/semaglutide) has not been addressed from a kidney perspective in clinical studies, it is known that amylin binds to G proteincoupled receptors in kidney and has been reported to influence proximal tubular sodium transport and activate the RAAS (83, 84)

This has the effect of lowering intraglomerular pressures and reducing single nephron GFR and subsequent proteinuria